Literature DB >> 11411729

Different patterns of silent cerebral infarct in patients with coronary artery disease or hypertension.

S Hoshide1, K Kario, T Mitsuhashi, Y Sato, Y Umeda, T Katsuki, K Shimada.   

Abstract

The aim of the present study was to clarify the differences in the progression and the characteristics of silent cerebral infarcts (SCI) between patients with coronary artery disease (CAD) and hypertensive patients. Silent cerebral infarcts, a powerful prognostic indicator for stroke, are frequently found in patients with CAD and in hypertensives. However, the differences in the characteristics of SCI and related risk factors between CAD and hypertensive patients have not been thoroughly investigated. We evaluated the number of SCI and their distribution using brain magnetic resonance imaging (T1- and T2-weighted images) in 107 patients with CAD (validated by coronary angiography) and 101 hypertensive patients without history of clinical stroke. The prevalence of multiple SCI (three or more infarcts per person) in patients with CAD and with hypertension was significantly higher than in hypertensives without CAD (46% v 21%; P = .001), whereas that of patients with CAD without hypertension was intermediate (31%). The patients with multi- (two- or three-vessel) vessel diseases (VD) had a significantly higher prevalence of multiple SCI than the hypertensives and the no-stenosis or 1-VD group (68.1% in the 3-VD group, 52.0% in the 2-VD group, 26.8% in the 1-VD group, and 21.0% in the no-stenosis group). Multiple logistic regression analysis revealed that in the CAD group, the number of involved coronary arteries was an independent determinant of SCI (P < .005), whereas in the hypertensive group, age was an independent determinant of SCI (P < .005). When we investigated the distribution of SCI, in the CAD group, SCI in the deep perforator territory (the basal ganglia and the thalamus) were independently associated with the number of involved coronary arteries (P < .005), whereas SCI in the white matter were independently associated with age only (P < .005). In conclusion, SCI were more advanced in the patients with multivessel CAD than in the hypertensive patients, and were more common in patients with CAD and hypertension than in those without hypertension. Coronary atherosclerosis was independently and specifically associated with SCI located in the deep perferator territory but not of SCI located in the white matter. The CAD-atherosclerosis and hypertension may be independently involved in the pathologic process of SCI.

Entities:  

Mesh:

Year:  2001        PMID: 11411729     DOI: 10.1016/s0895-7061(00)01293-0

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

Review 1.  Risk of "silent stroke" in patients older than 60 years: risk assessment and clinical perspectives.

Authors:  Jae-Sung Lim; Hyung-Min Kwon
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

2.  Silent brain infarction in the presence of systemic vascular disease.

Authors:  Julia Slark; Paul Bentley; Pankaj Sharma
Journal:  JRSM Cardiovasc Dis       Date:  2012-04-05

3.  Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly.

Authors:  Farzan Fatemi; Kejal Kantarci; Jonathan Graff-Radford; Gregory M Preboske; Stephen D Weigand; Scott A Przybelski; David S Knopman; Mary M Machulda; Rosebud O Roberts; Michelle M Mielke; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri
Journal:  Neurology       Date:  2018-01-17       Impact factor: 9.910

4.  Silent cerebral infarction in chronic heart failure: ischemic and nonischemic dilated cardiomyopathy.

Authors:  Guliz Kozdag; Ercument Ciftci; Dilek Ural; Tayfun Sahin; Macit Selekler; Aysen Agacdiken; Ali Demirci; Sezer Komsuoglu; Baki Komsuoglu
Journal:  Vasc Health Risk Manag       Date:  2008

5.  Prospective Study on the Incidence of Cerebrovascular Disease After Coronary Angiography.

Authors:  Akihiro Tokushige; Masaaki Miyata; Takeshi Sonoda; Ippei Kosedo; Daisuke Kanda; Takuro Takumi; Yuichi Kumagae; Yoshihiko Fukukura; Mitsuru Ohishi
Journal:  J Atheroscler Thromb       Date:  2017-08-30       Impact factor: 4.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.